Skip to main content
Thomas Hanscom, MD, Ophthalmology, Santa Monica, CA, Providence Saint John's Health Center

ThomasAlanHanscomMD

Ophthalmology Santa Monica, CA

Retinal Disease

Associate Clinical Professor of Ophthalmology, UCLA

Dr. Hanscom is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hanscom's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Ophthalmology, 1978 - 1979
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Ophthalmology, 1977 - 1978
  • University of Florida
    University of FloridaResidency, Ophthalmology, 1974 - 1977
  • University of Southern California/LACUSC Medical Center
    University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1973 - 1974
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - 2026
  • NC State Medical License
    NC State Medical License 1978 - 2002
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Super Doctor SuperDoctors.com
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Researchers Report One Drug More Effective in Treating Wet Age-Related Macular Degeneration
    Researchers Report One Drug More Effective in Treating Wet Age-Related Macular DegenerationApril 21st, 2023
  • Age-Related Macular Degeneration Expected to Affect 288 Million People by 2040
    Age-Related Macular Degeneration Expected to Affect 288 Million People by 2040January 17th, 2024
  • Alzheimer's: Could Blood Vessel Damage in the Eyes Be Driving Cognitive Impairment?
    Alzheimer's: Could Blood Vessel Damage in the Eyes Be Driving Cognitive Impairment?May 31st, 2023

Professional Memberships

Hospital Affiliations